Powder: -20°C for 3 years | In solvent: -80°C for 1 year
16beta,17-Dihydroxy-ent-kaurane-19-oic acid as an anti-HIV principle, it showed significant activity against HIV replication in H9 lymphocyte cells with an EC50 value of 0.8 microgram/mL. It also possesses the activities of decompression and blood viscosity depression.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 190.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 210.00 |
Description | 16beta,17-Dihydroxy-ent-kaurane-19-oic acid as an anti-HIV principle, it showed significant activity against HIV replication in H9 lymphocyte cells with an EC50 value of 0.8 microgram/mL. It also possesses the activities of decompression and blood viscosity depression. |
In vitro | Phytochemical analysis of the fruits of Annona squamosa yielded 12 known kaurane derivatives (1-11, 13) and two new kaurane diterpenoids, which have been named annosquamosin A (16 beta-hydroxy-17-acetoxy-ent-kauran-19-al) (12) and annosquamosin B (19-nor-ent-kaurane-4 alpha,16 beta,-17-triol) (14). The structures of the new compounds were established by spectral analyses and chemical evidence[1] |
Source |
Molecular Weight | 336.472 |
Formula | C20H32O4 |
CAS No. | 74365-74-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
16beta,17-Dihydroxy-ent-kaurane-19-oic acid 74365-74-5 Microbiology/Virology Proteases/Proteasome HIV Protease 16beta,17Dihydroxyentkaurane19oic acid 16beta,17 Dihydroxy ent kaurane 19 oic acid inhibitor inhibit